Admissions

Why Cornell Engineering?

"Scientists study the world as it is; engineers create the world that never has been."—Theodore von Karman

Cornell engineers challenge the status quo and do great things. Steeped in an environment of questioning, and with a focus on innovation, Cornell Engineering pursues excellence in all areas. Its faculty, students, and alumni design, build, and test products, improve the world of medicine, inform and shape our laws, create and drive businesses, become research luminaries, and overcome real and perceived barriers to achieve scientific breakthroughs that advance the quality of life on our planet.

We invite you to learn more about Cornell Engineering and its programs.

What type of applicant are you?

Did you know?

David Duffield, (Electrical Engineering, B.S., 1962), the namesake for Duffield Hall, is the founder of two ultra-successful enterprise software companies: PeopleSoft and Workday. Dufffield’s foundation Maddie’s Fund has supported no-kill animal shelters, including Tompkins County SPCA.

In 1883, the first course of study in electrical engineering in the world was introduced at Cornell. In 1889, Cornell established an electrical engineering department which was then incorporated into the College of Engineering.

In 2013, Prof. Uli Wiesner (MSE)and grad student Hiroaki Sai (M.S. 2011, PhD) announced the creation of a process for synthesizing hierarchical porous polymer films, which could be useful in applications ranging from catalysis to bioengineering.

Professor Robert K. Finn (B.S., Chemical Engineering, 1942) patented a process for treating wastes low in nitrogen with bacteria that fix nitrogen from the atmosphere. The process is still used today to treat certain types of food waste without creating any type of sludge and therefore without environmental damage.

Chris Prince (Ph.D., 1991) and Bobby Bringi (Chemical Engineering, Ph.D., 1991), formed Phyton Biotech that pioneered and commercialized a breakthrough plant-cell fermentation technology to produce the anti-cancer drug, Taxol, first extracted from the bark of the Pacific Yew tree.